Tumor necrosis factor-A is associated with positive lymph node status in patients with recurrence of colorectal cancer-indications for anti-TNF-A agents in cancer treatment

Cellular Oncology

Volumn 34, Issue 4, 2011, Pages 315-326

  Grimm, M ^a   Lazariotou, M ^a   Kircher, S ^b   Hofelmayr A ^a   Germer, C T ^a   Von Rahden, B H A ^a   Waaga Gasser, A M ^a   Gasser, M ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Apoptosis; Colorectal carcinoma; Death receptor signalling; Inflammation; Tumor escape mechanism

Indexed keywords

CD8 ANTIGEN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ANTINEOPLASTIC AGENT; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENT CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; ADENOCARCINOMA; COLORECTAL TUMOR; DISEASE COURSE; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LYMPH NODE; METABOLISM; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; PROGNOSIS; RECURRENT DISEASE; SURVIVAL; TUMOR ASSOCIATED LEUKOCYTE;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS; CD8-POSITIVE T-LYMPHOCYTES; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; OBSERVER VARIATION; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECURRENCE; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855306632     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-011-0027-7     Document Type: Article

References (55)

1. F. Adami, A. Guarini, M. Pini, F. Siviero, R. Sancetta, M. Massaia, L. Trentin, R. Foa, G. Semenzato, Serum levels of tumour necrosis factor-alpha in patients with B-cell chronic lymphocytic leukaemia. Eur J Cancer 30A(9), 1259-1263 (1994) (Pubitemid 24322058)
2. B.B. Aggarwal, Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol 3(9), 745-756 (2003) (Pubitemid 41070815)
3. A. Ashkenazi, V.M. Dixit, Death receptors: Signalling and modulation. Science 281(5381), 1305-1308 (1998)
4. S.J. Baker, E.P. Reddy, Modulation of life and death by the TNF receptor superfamily. Oncogene 17(25), 3261-3270 (1998) (Pubitemid 29043978)
5. F. Balkwill, Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev 13(2), 135-141 (2002) (Pubitemid 34229388)
6. F. Balkwill, A. Mantovani, Inflammation and cancer: Back to Virchow? Lancet 357(9255), 539-545 (2001) (Pubitemid 32173595)
7. F. Balkwill, L.M. Coussens, Cancer: An inflammatory link. Nature 431(7007), 405-406 (2004) (Pubitemid 39329565)
8. T.D. Brown, P. Goodman, T. Fleming, J.S. Macdonald, E.M. Hersh, T.J. Braun, A phase II trial of recombinant tumor necrosis factor in patients with adenocarcinoma of the pancreas: A SouthwestOncology Group study. J Immunother 10(5), 376-378 (1991)
9. M. Bueter, M. Gasser, N. Schramm, T. Lebedeva, G. Tocco, C. Gerstlauer, M. Grimm, E. Nichiporuk, A. Thalheimer, A. Thiede, D. Meyer, G. Benichou, A.M. Waaga-Gasser, T-cell response to p53 tumor-associated antigen in patients with colorectal carcinoma. Int J Oncol 28(2), 431-438 (2006)
10. F. Colotta, P. Allavena, A. Sica, C. Garlanda, A. Mantovani, Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis 30(7), 1073-1081 (2009)
11. C.C. Compton, L.P. Fielding, L.J. Burgart, B. Conley, H.S. Cooper, S.R. Hamilton, M.E. Hammond, D.E. Henson, R.V. Hutter, R.B. Nagle, M.L. Nielsen, D.J. Sargent, C.R. Taylor, M. Welton, C. Willett, Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124(7), 979-994 (2000) (Pubitemid 30602039)
12. D.R. Cox, Regression models and life tables. J R Stat Soc 34, 1987-2001 (1972)
13. E.T. Creagan, J.S. Kovach, C.G. Moertel, S. Frytak, L.K. Kvols, A phase I clinical trial of recombinant human tumor necrosis factor. Cancer 62(12), 2467-2471 (1988) (Pubitemid 19006423)
14. S. Cubillos, B. Scallon, M. Feldmann, P. Taylor, Effect of blocking TNF on IL-6 levels and metastasis in a B16-BL6 melanoma/mouse model. Anticancer Res 17(3C), 2207-2211 (1997) (Pubitemid 27320970)
15. J. Finke, S. Ferrone, A. Frey, A. Mufson, A. Ochoa, Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunol Today 20(4), 158-160 (1999) (Pubitemid 29172275)
16. A.B. Frey, N. Monu, Signalling defects in anti-tumor T cells. Immunol Rev 222, 192-205 (2008)
17. W.L. Furman, D. Strother, K. McClain, B. Bell, B. Leventhal, C. B. Pratt, Phase I clinical trial of recombinant human tumor necrosis factor in children with refractory solid tumors: A Pediatric Oncology Group study. J Clin Oncol 11(11), 2205-2210 (1993)
18. P. Geborek, A. Bladstrom, C. Turesson, A. Gulfe, I.F. Petersson, T. Saxne, H. Olsson, L.T. Jacobsson, Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis 64(5), 699-703 (2005) (Pubitemid 40559295)
19. F.L. Greene, TNM staging for malignancies of the digestive tract: 2003 changes and beyond. Semin Surg Oncol 21(1), 23-29 (2003) (Pubitemid 37127471)
20. Grimm M, Kim M, von Rahden B, Meier E, Tsaur I, Rosenwald A, Germer CT, Gasser M and W.-G. AM., Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer, Eur J Cancer accepted (2010).
21. Grimm M, Gasser M, Bueter M, Otto C, Strehl J, Wang J, Nichiporuk E, Germer CT, Meyer D, Waaga-Gasser AM and T. A., Immunological escape mechanisms of colorectal hepatic metastases, BMC Cancer accepted (2010).
22. A.L. Hamilton SR, Pathology and genetics of tumours of the digestive system. Tumours of small intestine (IARC, Lyon, 2000), pp. 69-91
23. D. Hanahan, R.A. Weinberg, The hallmarks of cancer. Cell 100 (1), 57-70 (2000) (Pubitemid 30046295)
24. D. Holzel, J. Engel, U. Lohrs, Elective lymph node dissections-still a standard in cancer surgery? Zentralbl Chir 133(6), 582-589 (2008)
25. D. Holzel, R. Eckel, J. Engel, Colorectal cancer metastasis. Frequency, prognosis, and consequences. Chirurg 80(4), 331-340 (2009)
26. A.G. Jarnicki, J. Lysaght, S. Todryk, K.H. Mills, Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: Influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells. J Immunol 177(2), 896-904 (2006) (Pubitemid 44036590)
27. E.L. Kaplan, P. Meier, Nonparametric estimation from incomplete observations. J Am Stat Assoc 75, 457-487 (1958)
28. S. Lankiewicz, E. Rother, S. Zimmermann, C. Hollmann, F. Korangy, T.F. Greten, Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells. Cell Oncol 30(6), 463-471 (2008)
29. S.T. Malik, M.S. Naylor, N. East, A. Oliff, F.R. Balkwill, Cells secreting tumour necrosis factor show enhanced metastasis in nude mice. Eur J Cancer 26(10), 1031-1034 (1990)
30. A. Mantovani, Cancer: Inflaming metastasis. Nature 457(7225), 36-37 (2009)
31. W.E. Mesker, G.J. Liefers, J.M. Junggeburt, G.W. van Pelt, P. Alberici, P.J. Kuppen, N.F. Miranda, K.A. van Leeuwen, H. Morreau, K. Szuhai, R.A. Tollenaar, H.J. Tanke, Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients. Cell Oncol 31 (3), 169-178 (2009)
32. V. Michalaki, K. Syrigos, P. Charles, J. Waxman, Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer 90(12), 2312-2316 (2004) (Pubitemid 38961893)
33. D.W. Miles, L.C. Happerfield, M.S. Naylor, L.G. Bobrow, R.D. Rubens, F.R. Balkwill, Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissue. Int J Cancer 56(6), 777-782 (1994) (Pubitemid 24102739)
34. C.P. Morales, R.F. Souza, S.J. Spechler, Hallmarks of cancer progression in Barrett's oesophagus. Lancet 360(9345), 1587-1589 (2002) (Pubitemid 35356377)
35. J.R. Muppidi, J. Tschopp, R.M. Siegel, Life and death decisions: Secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 21(4), 461-465 (2004) (Pubitemid 39370502)
36. J. Nakashima, M. Tachibana, M. Ueno, A. Miyajima, S. Baba, M. Murai, Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer. Clin Cancer Res 4(7), 1743-1748 (1998) (Pubitemid 28304737)
37. M.S. Naylor, G.W. Stamp, W.D. Foulkes, D. Eccles, F.R. Balkwill, Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest 91(5), 2194-2206 (1993) (Pubitemid 23141496)
38. P. Orosz, B. Echtenacher, W. Falk, J. Ruschoff, D. Weber, D.N. Mannel, Enhancement of experimental metastasis by tumor necrosis factor. J Exp Med 177(5), 1391-1398 (1993) (Pubitemid 23117129)
39. Z. Qin, S. Kruger-Krasagakes, U. Kunzendorf, H. Hock, T. Diamantstein, T. Blankenstein, Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis. J Exp Med 178(1), 355-360 (1993) (Pubitemid 23173272)
40. S. Rajput, A. Wilber, Roles of inflammation in cancer initiation, progression, and metastasis. Front Biosci (Schol Ed) 2, 176-183 (2010)
41. J.C. Reed, Apoptosis-targeted therapies for cancer. Cancer Cell 3 (1), 17-22 (2003) (Pubitemid 37443888)
42. M.J. Sack, S.A. Roberts, Cytokeratins 20 and 7 in the differential diagnosis of metastatic carcinoma in cytologic specimens. Diagn Cytopathol 16(2), 132-136 (1997) (Pubitemid 27106514)
43. H.I. Sati, M. Greaves, J.F. Apperley, R.G. Russell, P.I. Croucher, Expression of interleukin-1beta and tumour necrosis factor-alpha in plasma cells from patients with multiple myeloma. Br J Haematol 104(2), 350-357 (1999) (Pubitemid 29083345)
44. P. Selby, S. Hobbs, C. Viner, E. Jackson, A. Jones, D. Newell, A. H. Calvert, T. McElwain, K. Fearon, J. Humphreys et al., Tumour necrosis factor in man: Clinical and biological observations. Br J Cancer 56(6), 803-808 (1987) (Pubitemid 18048357)
45. P.E. Shrout, J.L. Fleiss, Intraclass correlations: Uses in assessing rater reliability. Psychol Bull 86(2), 420-428 (1979)
46. J.S. Smolen, D. Aletaha, Developments in the clinical understanding of rheumatoid arthritis. Arthritis Res Ther 11(1), 204 (2009)
47. Sobin LH and W. Ch., UICC. TNM Classification of Malignant Tumors, 6th edition (2002).
48. L.A. Tartaglia, D.V. Goeddel, Two TNF receptors. Immunol Today 13(5), 151-153 (1992)
49. S. Trompet, A.J. de Craen, S. Mooijaart, D.J. Stott, I. Ford, N. Sattar, W. Jukema, R.G. Westendorp, High innate production capacity of proinflammatory cytokines increases risk for death from cancer: Results of the PROSPER study. Clin Cancer Res 15 (24), 7744-7748 (2009)
50. P. Vandenabeele, W. Declercq, R. Beyaert, W. Fiers, Two tumour necrosis factor receptors: Structure and function. Trends Cell Biol 5(10), 392-399 (1995)
51. L.M. Veenendaal, O. Kranenburg, N. Smakman, A. Klomp, I.H. Borel Rinkes, P.J. van Diest, Differential Notch and TGFbeta signalling in primary colorectal tumors and their corresponding metastases. Cell Oncol 30(1), 1-11 (2008) (Pubitemid 351161033)
52. K. Warzocha, P. Ribeiro, N. Renard, J. Bienvenu, C. Charlot, B. Coiffier, G. Salles, Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas. Cancer Immunol Immunother 49(9), 469-475 (2000)
53. Y. Wu and B. P. Zhou, TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion, Br J Cancer. 2009
54. I. Zidi, S. Mestiri, A. Bartegi, N. B. Amor, TNF-alpha and its inhibitors in cancer, Med Oncol (2009). 55. K. Zins, D. Abraham, M. Sioud, S. Aharinejad, Colon cancer cellderived tumor necrosis factor-alpha mediates the tumor growthpromoting response in macrophages by up-regulating the colonystimulating factor-1 pathway. Cancer Res 67(3), 1038-1045 (2007)
55. C.C. Zouboulis, K. Schroder, C. Garbe, K. Krasagakis, S. Kruger, C.E. Orfanos, Cytostatic and cytotoxic effects of recombinant tumor necrosis factor-alpha on sensitive human melanoma cells in vitro may result in selection of cells with enhanced markers of malignancy. J Invest Dermatol 95(6 Suppl), 223S-230S (1990)